Temple, TX, United States of America

Gavin W Roddy

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 3.9

ph-index = 1

Forward Citations = 9(Granted Patents)


Location History:

  • Temple, TX (US) (2014 - 2016)
  • Rochester, MN (US) (2015 - 2018)

Company Filing History:


Years Active: 2014-2018

Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Gavin W Roddy: Innovator in Ocular Treatments

Introduction

Gavin W Roddy is a notable inventor based in Temple, TX (US). He has made significant contributions to the field of ocular treatments, holding a total of 7 patents. His work focuses on utilizing adult stem cells and progenitor cells for the treatment of eye injuries and diseases.

Latest Patents

Roddy's latest patents encompass methods and compositions for treating ocular diseases, disorders, or conditions in mammals. His inventions include a population of mesenchymal stromal cells that possess anti-inflammatory, anti-apoptotic, immune modulatory, and anti-tumorigenic properties. The administration of TSG-6, STC-1, or a combination thereof is included as a treatment for ocular diseases, disorders, or conditions in mammals.

Career Highlights

Throughout his career, Gavin W Roddy has worked with esteemed organizations such as the Texas A&M University System and Scott & White Healthcare. His innovative research has paved the way for advancements in ocular health and treatment methodologies.

Collaborations

Roddy has collaborated with notable individuals in his field, including Darwin J Prockop and Robert Rosa. These partnerships have contributed to the development and success of his inventions.

Conclusion

Gavin W Roddy's work in the field of ocular treatments showcases his dedication to innovation and improving health outcomes. His contributions through patents and collaborations highlight the importance of research in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…